Analyst consensus rating
Xenon Pharmaceuticals Analyst Rating: Strong Buy
XENE is rated Strong Buy by 19 analysts with a $81.30 target. As of 2026-08-31.
Direct answer
Xenon Pharmaceuticals's consensus rating is Strong Buy.
19 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $81.30.
Forecast evidence checked August 31, 2026.
Get free Xenon Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $59.99
- Average price target
- $81.30
- High price target
- $100.00
- Low price target
- $69.00
- Low target gap
- +15%
- Target upside
- +35.5%
- High target gap
- +66.7%
- Target range width
- 51.7%
- Consensus rating
- Strong Buy
- Analysts
- 19
- Evidence date
- August 31, 2026
- Valid through
- September 7, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Xenon Pharmaceuticals?
Xenon Pharmaceuticals has a verified Strong Buy consensus. The same dataset has an average price target of $81.30.
How far are Xenon Pharmaceuticals's low and high targets from the recorded price?
The low target implies +15%, while the high target implies +66.7%.
How many analysts are included in Xenon Pharmaceuticals's consensus?
The verified consensus includes 19 analysts.
How is Xenon Pharmaceuticals's target upside or downside calculated?
The average target of $81.30 is divided by the recorded price of $59.99, then one is subtracted to produce +35.5%. This does not guarantee a future return.
When was Xenon Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-08-31. The dataset is valid through 2026-09-07.